Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.42%
Monthly Change
-18.98%
6 month change
+32.78%
Cambio anual
+17.73%
Cierres anteriores
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volumen
70
Markets
Acciones
Atención Sanitaria
ZNTL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
La directora ejecutiva de Zentalis Pharma, Eastland, vende acciones por 21.000 dólares
Zentalis Pharma CEO Eastland sells $21k in shares
El director médico de Zentalis Pharma, Bruns, vende acciones por 7.998 dólares
Zentalis Pharma CMO Bruns sells $7998 in stock
PAO de Zentalis Pharmaceuticals vende acciones por $7.8 mil
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Objetivo de precio de Zentalis Pharmaceuticals reducido a 2 dólares en Leerink Partners
Leerink Partners reduce precio objetivo de Zentalis Pharmaceuticals a $2
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting